Cyclin-dependent kinases (CDKs) trigger essential cell cycle processes including critical events in G1 phase that culminate in bud emergence, spindle pole body duplication, and DNA replication. Localized activation of the Rhotype GTPase Cdc42p is crucial for establishment of cell polarity during G1, but CDK targets that link the Cdc42p module with cell growth and cell cycle commitment have remained largely elusive. Here, we identify the GTPaseactivating protein (GAP) Rga2p as an important substrate related to the cell polarity function of G1 CDKs. Overexpression of RGA2 in the absence of functional Pho85p or Cdc28p CDK complexes is toxic, due to an inability to polarize growth. Mutation of CDK consensus sites in Rga2p that are phosphorylated both in vivo and in vitro by Pho85p and Cdc28p CDKs results in a loss of G1 phase-specific phosphorylation. A failure to phosphorylate Rga2p leads to defects in localization and impaired polarized growth, in a manner dependent on Rga2p GAP function. Taken together, our data suggest that CDK-dependent phosphorylation restrains Rga2p activity to ensure appropriate activation of Cdc42p during cell polarity establishment. Inhibition of GAPs by CDK phosphorylation may be a general mechanism to promote proper G1-phase progression.
Introduction
All cells can polarize, either to adapt to changes in the extracellular environment or in response to internal cues (Pruyne and Bretscher, 2000a, b) . Cell transformation and enhanced metastatic potential also demand alterations of the actin cytoskeleton, which in its normal context is dynamically rearranged during the cell cycle to ensure proper cell polarity, division, motility, and survival. For example, members of the Rho family of small GTPases, which are critical intracellular mediators of actin-modeling events, have been causally linked, either directly or through their effectors, to oncogenic transformation and metastasis (Clark et al, 2000; Pawlak and Helfman, 2001; Frame and Brunton, 2002) .
As for other fundamental biological processes, studies using the budding yeast Saccharomyces cerevisiae have identified many of the conserved regulators controlling cell polarity. The budding yeast orients its growth every cell cycle toward a specific site, ultimately leading to the formation of a daughter cell. An essential and well-characterized event required for polarization of growth in eukaryotic cells is the local activation of the conserved Rho-type GTPase Cdc42p (Johnson, 1999; Etienne-Manneville, 2004) . The regulated cycling of Cdc42p between GTP-and GDP-bound states is perpetuated by the antagonistic activity of two types of factors, guanine-nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). The sole GEF for Cdc42p, Cdc24p, functions to restrict Cdc42p activity to a single concentrated region at the plasma membrane. In haploid yeast cells, Cdc24p is kept sequestered in the nucleus via a physical interaction with Far1p (Toenjes et al, 1999; Nern and Arkowitz, 2000; Shimada et al, 2000) . In G1 phase of the cell cycle, Cln-Cdc28p cyclin-dependent kinases (CDKs) phosphorylate and trigger the degradation of Far1p, allowing Cdc24p to exit the nucleus (Henchoz et al, 1997) . In a process requiring the adaptor protein Bem1p, Cdc24p is recruited to local sites at the plasma membrane in a ClnCdc28p-dependent and actin-independent process, leading to the scaffold-mediated 'symmetry breaking' and local activation and cycling of Cdc42p (Butty et al, 2002; Irazoqui et al, 2003; Shimada et al, 2004) . While only one GEF for Cdc42p has been uncovered in yeast, four GAPs-Rga1p, Rga2p, Bem3p, and Bem2p-can stimulate the hydrolysis of Cdc42-GTP in vitro (Marquitz et al, 2002; Smith et al, 2002) . Although genetically redundant for viability, all four GAPs have different localization patterns through the cell cycle, suggesting distinct functional roles (M Peter and E Bi, personal communication) . Despite their clear importance, the influence of the various GAPs on the proper localization and timing of Cdc42p activation in vivo remains poorly understood.
G1-specific forms of the CDKs Cdc28p and Pho85p are required for early cell cycle progression in yeast. Cdc28p and Pho85p phosphorylate multiple targets to allow proper coordination of morphogenesis, budding, DNA replication, and other events associated with commitment to the mitotic cell cycle (Moffat et al, 2000; Bloom and Cross, 2007) . These events include, but are not restricted to, (1) the phosphorylation of the transcriptional repressor Whi5p to initiate G1 phase-specific transcription (Costanzo et al, 2004; de Bruin et al, 2004 ; D Huang and BJ Andrews, unpublished) and (2) the phosphorylation of Far1p, leading to release of Cdc24p from the nucleus. Targeting of Far1p, however, is unlikely the sole role for the Cln-Cdc28p CDKs in regulating unidirectional growth, since a cytoplasmic form of Cdc24p is unable to induce polarization of growth in the absence of the Cdc28p G1 cyclins (Nern and Arkowitz, 2000) . The G1-specific Cdc28p cyclins (Clns) are also required for the formation of localized Cdc42p-GTP . Indeed cells lacking a burst of late-G1 cyclin-CDK activity fail to properly orient growth and undergo morphogenetic catastrophe, halting the cell cycle at the morphogenesis checkpoint in G2 phase (Moffat and Andrews, 2004) .
We used a functional genomics approach to identify new targets of G1-specific CDKs involved in polarized cell growth (Sopko et al, 2006) . A systematic synthetic dosage lethality (SDL) screen identified the Cdc42p GAP Rga2p as a potential substrate of Pho85p (Sopko et al, 2006) . Here, we demonstrate that G1-specific forms of both Pho85p and Cdc28p phosphorylate and inhibit Rga2p to contribute to the appropriate activation of Cdc42p. Inhibition of GAPs by CDKs may be a general mechanism linking cell polarity regulation with cell cycle progression.
Results

Orthogonal genomic data sets implicate Rga2p as a Pho85 target
We combined an automated yeast genetics platform called synthetic genetic array (SGA) analysis with a yeast overexpression array, to enable a systematic approach to examine SDL interactions. Array-based SDL screens permit systematic analysis of gain-of-function phenotypes and are based on the idea that deleterious effects of gene overexpression are often seen only in specific genetic backgrounds (Sopko et al, 2006) . With this in mind, we screened a strain deleted for the PHO85 CDK and discovered 65 genes that cause lethality or slow growth specifically in the absence of the kinase (Sopko et al, 2006) . We reasoned that since many known Pho85p substrates are negatively regulated by phosphorylation, an SDL interaction might reflect an accumulation of unmodified substrate. Consistent with this idea, the SDL data set was highly enriched for known in vivo substrates of the Pho85p kinase. To aid prioritization of other SDL hits for follow-up studies, we compared the pho85D SDL profile to the spectrum of in vitro substrates for various forms of Pho85p identified using proteome chips coupled with in vitro kinase assays (Ptacek et al, 2005) . Several proteins were identified in both screens, including the calcium-responsive transcription factor, Crz1p, which we confirmed as a previously unappreciated in vivo target of Pho85p using a variety of assays (Sopko et al, 2006) . The GAP, Rga2p, was another protein identified in both the SDL and proteome chip screens (Ptacek et al, 2005; Sopko et al, 2006) . RGA2 is one of four genes in yeast encoding GAPs that act specifically to stimulate GTP hydrolysis by the Rho-type GTPase Cdc42p (Smith et al, 2002) . Cdc42p-mediated GTP hydrolysis appears critical for the propagation and/or dissolution of an interaction between Cdc42p and downstream effectors, ultimately leading to the firing of specific pathways such as septin ring and actin filament assembly and organization. The results of our large-scale screens suggest that Pho85p-dependent phosphorylation of Rga2p may explain the clear role for Pho85p in cell polarity and morphogenesis, for which key substrates remain unidentified, an idea that we chose to explore.
Overexpression of RGA2 in G1 cyclin mutants produces a G1 morphology and slow-growth phenotype We reasoned that if Pho85p were phosphorylating Rga2p in vivo, a specific Pho85p-cyclin complex might be involved. Since Pho85p has a clear role in regulating morphogenesis in G1 phase (Moffat and Andrews, 2004) , we chose to focus on G1-specific forms of Pho85p as potential Rga2p kinases. We predicted that, like the pho85D kinase mutant, RGA2 overexpression in a mutant lacking the relevant Pho85p cyclin(s) would result in a significant fitness defect. Pho85p is activated by three G1-specific cyclins, Pcl1p, Pcl2p, and Pcl9p, and we found that overexpression of RGA2 produced a growth defect in strains deleted for various combinations of these G1 cyclins ( Figure 1A , pcl1D, pcl2D, and pcl9Ddouble and triple mutants). The overexpression of RGA2 in other Pho85p cyclin mutant backgrounds failed to have any discernable effect (data not shown). Effects in single mutants were less dramatic, consistent with the documented genetic redundancy of these G1 cyclins (Measday et al, 1997; Huang et al, 2002) . We saw a similar inhibition of growth when RGA2 was overexpressed in a strain lacking CLN1 and CLN2, the G1 cyclin counterparts for the CDK, Cdc28p ( Figure 1A ). This growth inhibition cannot be explained by an increased stability of Rga2p in these mutants, given that we saw no substantial differences in Rga2p levels in these mutants by Western blot (Supplementary Figure 1) . A significant fraction of the double and triple clnD and pclDmutants overexpressing RGA2 arrested with a large, round unbudded cell morphology ( Figure 1B , pcl1Dpcl2D: 37%, pcl1Dpcl9D: 33%, and pcl1Dpcl2D pcl9D: 40%). This morphogenetic defect is similar to that seen in mutant strains bearing cdc24 loss-of-function alleles (Hartwell et al, 1974; Sloat et al, 1981; Zheng et al, 1994) . Since Cdc24p, the GEF for Cdc42p, opposes the function of Cdc42p GAPs, our genetic results suggest that Rga2p is hyperactive when overexpressed in G1 CDK mutants.
G1-specific Pho85p cyclins have overlapping localization with Rga2p and interact physically with Rga2p
Rga2p localizes to sites of polarized growth including the incipient bud site and bud tip, as well as the bud neck (Caviston et al, 2003) . Coincident localization of Rga2 with relevant in vivo kinases should be detectable, and Pcl1p and Pcl2p are known to localize to the same regions of polarized growth ( Figure 2A ; Moffat and Andrews, 2004) . Given the genetic redundancy we detected for RGA2 SDL phenotypes, we asked if, like Pcl1p and Pcl2p, a GFP-tagged version of Pcl9p had overlapping localization with Rga2p ( Figure 2A) . We identified the bud neck and incipient bud site as the principal sites of Pcl9p localization (Figure 2A ). Together with our genetic observations, these localization data suggest the G1-specific Pcls are the relevant cyclins for targeting Pho85p-dependent phosphorylation of Rga2p.
The physical interaction of kinases and their substrates can often be detected directly by copurification of the proteins or indirectly by association of kinase activity with the substrate. In particular, cyclins are known to function as substratetargeting subunits (Miller and Cross, 2001) , and several interactions between cyclins and Pho85p targets have been reported (Huang et al, 1998; Friesen et al, 2003) . We asked whether we could detect a physical interaction between Rga2p and any of the G1-specific Pho85p cyclins. We used a FLAG-tagged version of RGA2 to efficiently immunoprecipitate full-length Rga2p-FLAG from yeast extracts ( Figure 2B , lanes 5-8). We detected copurification of Rga2p-FLAG and Pcl1p, Pcl2p, or Pcl9p from extracts prepared from strains expressing 13xMYC-PCL1, 13xMYC-PCL2, or 13xMYC-PCL9 ( Figure 2B , lanes 6-8, respectively). These data suggest a direct physical interaction between Rga2p-and G1-specific Pcl cyclins, consistent with a role for the Pcls in targeting Rga2p to the Pho85p kinase.
G1-specific CDK complexes phosphorylate Rga2p at distinct sites in vitro and in vivo
Rga2p possesses 18 potential CDK phosphorylation sites (S/TP; Figure 3A ). Using five purified Rga2p protein fragments ( Figure 3A , bottom) we performed in vitro kinase assays with recombinant Pho85p-Pcl and Cdc28p-Cln complexes to hone in on relevant sites of CDK phosphorylation. Fragments Rga2_2 and Rga2_4, both of which contain small clusters of S/TP sites, were excellent in vitro substrates for Pho85p-Pcl1p (data not shown), Pho85p-Pcl2p ( Figure 3B ), or Pho85p-Pcl9p (data not shown), while Cdc28p-Cln2p detectably phosphorylated all Rga2p peptides except Rga2_5 ( Figure 3C ). Interestingly, Rga2_5, the peptide encompassing the GAP domain failed to be efficiently phosphorylated by any of the kinases. Coomassie Blue-stained gels corresponding to these autoradiographs are included in the Supplementary data for reference (Supplementary Figure 2) . We subjected the in vitro phosphorylated peptides to mass spectrometry analysis and identified nine sites within the Rga2_2 and Rga2_4 peptides (T320, S330, S334, T561, S692, S763, S770, S772, and T779) that were phosphorylated by pho85D, pcl1D, pcl2D, pcl9D, pcl1Dpcl2D, pcl2Dpcl9D, pcl1Dpcl9D, pcl1Dpcl2Dpcl9D , and cln1Dcln2D strains bearing either pGST-RGA2 or vector were spotted in serial 15-fold dilutions on medium containing galactose and incubated at 301C for 72 h. (B) Overexpression of RGA2 in G1 phase-specific Pho85p cyclin mutants results in an accumulation of large, round, and unbudded cells. The morphology of those strains (top panels) from panel A was examined following 72 h of growth on galactose-containing medium. Cells were visualized at Â 630 magnification. Size bar is 10 mm. The number in the bottom right corner refers to the percentage of cells displaying a large, unbudded phenotype within the population relative to the vector control (bottom panel); 4200 cells were counted for each sample.
Pho85p-Pcl complexes in vitro (Table I) . Five sites clustered in fragment Rga2_4 were also clearly phosphorylated in vitro by Cdc28p-Cln2p (S692, S763, S770, S772, and T779; Table I ). Our failure to detect phosphorylated peptides by mass spectrometry on the other Rga2p fragments that were phosphorylated in vitro by Cdc28p ( Figure 3C ) may reflect variability in the kinase assay or a lack of enrichment for peptides encompassing these Rga2p fragments following protein digestion and derivatization.
Next, we sought to identify relevant in vivo sites of phosphorylation within Rga2p. We purified a C-terminally FLAG-tagged version of Rga2p from yeast extracts and identified eight in vivo sites of phosphorylation using mass spectrometry analysis (S334, S380, S692, S707, S733, S763, S770, and S772; Table I ). Six of these sites were phosphorylated both in vivo and in vitro (Table I) , while other phosphopeptides were detected only in one assay (in vitro: T320, S330, T561, and T779; in vivo: S380 and S707). In any case, the significant overlap between phosphorylation patterns seen in our CDK kinase assays and on Rga2p in vivo strongly supports the hypothesis that Rga2p is a substrate for G1 CDKs.
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Figure 2 G1-specific Pho85 cyclins have overlapping localization and interact physically with Rga2p. (A) Localization of G1-specific Pho85 cyclins to sites of polarized growth. The localization of GFP-tagged Pcls was examined by confocal microscopy following expression of GFP-PCL1, GFP-PCL2, or GFP-PCL9 from their native promoters on high-copy plasmids. The localization pattern of Rga2p-GFP expressed from its native chromosomal locus is also shown (bottom). (B) Co-immunoprecipitation of G1-specific Pcl cyclins with Rga2p. Extracts from strains coexpressing FLAG and vector, or RGA2-FLAG and vector (lanes 1 and 5, respectively); FLAG and 13xMYC-PCL1, or RGA2-FLAG and 13xMYC-PCL1 (lanes 2 and 6, respectively); FLAG and 13xMYC-PCL2, or RGA2-FLAG and 13xMYC-PCL2 (lanes 3 and 7, respectively); FLAG and 13xMYC-PCL9, or RGA2-FLAG and PCL9-13xMYC (lanes 4 and 8, respectively), were used to immunoprecipitate (IP) Rga2p. Rga2p-FLAG was detected by Western blot analysis using anti-FLAG antibodies. 13xMYC-tagged Pcls were detected by immunoblotting (IB) with anti-MYC antibodies. A total of 10% of input cell extract was loaded as a control (CE). 
To further test this hypothesis, we purified Rga2p protein from pho85D and cln1Dcln2D mutants to assess alterations in Rga2p phosphorylation. We failed to detect phosphorylation at three sites (S334, S380, and S707; Table I ) when Rga2p was purified from a pho85D strain, whereas phosphorylation of only S380 appeared dependent on CLN1 and CLN2 (Table I) . Although we cannot exclude the possibility that an insufficient enrichment for derivatized peptides encompassing sites S380 and S707 is underrepresenting phosphorylation, we predict that a lack of phosphorylation detected at these sites is indicative of their CDK-dependent phosphorylation. On the other hand, we recovered significant derivatization of nonphosphorylated peptides encompassing S334 in pho85D, indicating that phosphorylation at this site is indeed dependent on Pho85p activity in vivo. The differential phosphorylation of Rga2p by Pho85p-Pcl and Cdc28p-Cln complexes suggests that these kinases may each contribute to the regulation of Rga2p via phosphorylation, both at unique and potentially overlapping sites (Table II) .
Overexpression of RGA2 mutated at phosphorylation sites causes growth defects and an accumulation of large, unbudded cells
To further substantiate the view that G1 CDKs phosphorylate Rga2p to regulate its activity, we analyzed the phenotype associated with overexpression of versions of Rga2p mutated at various S/TP sites. Rather than focusing solely on those residues implicated as in vivo sites by our biochemical analysis, we chose a broader approach that considered potential phosphorylation sites of Rga2p conserved among fungal species, as well as sites conserved among all Cdc42 GAPs (see Figure 4A ). We expressed mutant alleles of Rga2p lacking one or more of 13 different S/TP sites (S/T-A substitutions) in wild-type cells. Although S380 was phosphorylated in our wild-type Rga2p purification, we were unable to test the function of an S380A mutant as the mutant protein is unstable. Nonetheless, we predicted that expression of a hypo-phosphorylated version of RGA2 might mimic the effect we saw when overexpressing wild-type RGA2 in a pho85D strain or various CDK mutants. Overexpression of Rga2p mutants lacking any single site, or several double-site combinations, had no obvious phenotypic consequence relative to wild-type Rga2p ( Figure 4A ). Certain alanine substitution combinations, however, showed a pronounced phenotypic consequence and these effects were additive. An Rga2p mutant carrying eight substitutions (S160A, S330A, S334A, S707A, S751, S763, S770A, and S772A; hereafter referred to as Rga2 8A p) had the most dramatic effect on growth when overexpressed in wild-type cells ( Figure 4A, RGA2 8A was expressed at levels comparable to wild-type RGA2; Figure 4F ). The residues altered in the Rga2 8A p mutant include five serine residues that were phosphorylated both in vivo and in vitro (see above and Table I ). Expressing RGA2 8A in wild-type cells phenocopied the overexpression of wild-type RGA2 in CDK mutants; a large proportion (B47%) of cells displayed a large, round unbudded cell morphology after 6 h in galactose ( Figure 4B ). The morphological effects of expressing quadruple-and quintuple-site mutants were similar to that of the 8 Â mutant Rga2 8A , however more subtle. Notably, overexpression of RGA2 8A is still lethal in pho85D and cln1Dcln2D mutant strains, as we would predict if these kinases were responsible for phosphorylating Rga2p (data not shown) and overexpression of PCL1, PCL2, or PCL9 is unable to suppress RGA2 8A -associated toxicity (Supplementary Figure 3) . In addition, RGA2
8A exacerbated the temperature sensitivity and unbudded phenotype of a cdc24-4 strain ( Figure 4C ). Together, our biochemical and genetic data suggest that a deficiency of CDK-dependent phosphorylation of Rga2p leads to significant G1 defects, most consistent with a failure to negatively regulate Rga2p function.
Abolishment of Rga2p GAP function suppresses G1 defects of wild-type cells overexpressing RGA2
8A
To ask whether the phenotype displayed by wild-type cells overexpressing RGA2
8A was due to unrestricted Rga2p GAP activity, we chose to mutate a conserved lysine residue (K872) within the GAP domain of Rga2p, previously shown to be essential for activation of the mammalian RhoA GTPase by the GAP p190 (Li et al, 1997) . Furthermore, mutation of this residue to alanine resulted in elimination of GAP activity for Rga1p, another S. cerevisiae Cdc42p GAP, in vitro (Gladfelter et al, 2002) , and diminished the interaction between the Rga1p GAP domain and Cdc42p. Substitution of lysine 872 with alanine in Rga2 8A p resulted in the suppression of both the large, unbudded morphology ( Figure 4B ) and growth inhibition ( Figure 4D ) produced by RGA2 8A overexpression. Mutation of the GAP domain reduced the large cell size of RGA2 8A -expressing cells from 67 to 42 fl, near the size of cells expressing vector or wild-type RGA2 ( Figure 4E ). Suppression of RGA2 8A overexpression defects by mutation of Figure 4 Functional analysis of RGA2 mutations. (A) A wild-type strain bearing either vector, pGAL-RGA2, or plasmids expressing RGA2 mutated at potential CDK phosphorylation sites was spotted in serial 15-fold dilutions on galactose medium and incubated at 301C for 72 h. The schematic of full-length Rga2p shows those potential CDK phosphorylation sites (asterisks; S/TP) mutated to alanine. The version comprising the eight alanine substitutions, S330A, S334A, S707A, S751A, S160A, S763A, S770A, S772A, is referred to as RGA2 -FLAG were induced in galactose for 6 h and examined by microscopy. Cells were visualized at Â 400 magnification. Size bar is 10 mm. The number in the bottom right corner refers to the percentage of cells displaying a large, unbudded phenotype relative to the vector control; 4400 cells were counted. (C) A cdc24-4 strain bearing the RGA2 8A allele at the endogenous RGA2 locus was spotted in serial 15-fold dilutions on rich medium, and incubated at semi-permissive temperatures. Cell morphology was examined using differential interference contrast (DIC) microscopy at Â 400 magnification. Size bar is 10 mm. -FLAG were expressed in low copy under the regulation of the GAL1 promoter in wild-type cells. Cells were induced with galactose for 3 h. Expression was monitored by Western blot analysis with a-FLAG antibodies (top panel) and compared to levels of Swi6 detected in extracts using a-Swi6 antibodies (bottom panel).
the GAP domain implies that hypo-phosphorylation of Rga2p leads to hyperactive GAP function. hyperactive GAP (Rga2p) activity, and would be evident as decreased levels of GTP-bound Cdc42p in vivo. We used a CRIB domain from the human PAK1 kinase, a known Cdc42p effector, in a GST pull-down assay to specifically recover Cdc42p-GTP from yeast cell extracts (Caviston et al, 2002; Aguilar et al, 2006) . We reproducibly recover less Cdc42-GTP from CDK mutant extracts ( Figure 5A , lanes 5-7), in particular from a pho85D extract ( Figure 5A , lane 5; see also Supplementary Figure 4) . Expression of RGA2 8A from the RGA2 chromosomal locus has little effect on growth, unless sensitized by reduction of function of CDC24 ( Figure 4C ). Consistent with this observation, we see only a slight decrease in the levels of Cdc42p-GTP when RGA2
Levels of activated
8A is expressed at endogenous levels, compared with wild type ( Figure 5A , lane 1 versus lane 2). As well, we see relatively reduced levels of Cdc42-GTP when Rga2
8A is the only endogenous GAP (RGA2 8A bem3Drga1D versus rga2Dbem3Drga1D; Figure 5A , lane 3 versus lane 4). A shift in the amount of Cdc42p-GTP relative to total Cdc42p suggests either (1) a decrease in the activity of the Cdc42p GEF, Cdc24p, or (2) an increase in the activity of a Cdc42p GAP(s). Nonetheless, these data are consistent with our model that phosphorylation restricts Rga2p activity and that Rga2p is hyperactive in the absence of Pho85p function due to a lack of phosphorylation. This hypothesis is further strengthened by the fact deletion of PCL1 and PCL2 exacerbates the phenotype of a cdc24-4 strain ( Figure 5B ).
Rga2
8A p fails to accumulate G1 phase-specific phosphoforms To substantiate the kinase-substrate relationship between G1 CDKs and Rga2p in vivo, we used a TAP-tagged version of Rga2p to examine Rga2p phosphoforms throughout the cell cycle. For these experiments, synchronized cells were released from a G1 arrest and samples were taken periodically for Western blotting. We found that Rga2p underwent an electrophoretic mobility shift 30-45 min after release from G1 arrest, coincident with DNA replication and bud emergence ( Figure 6A ). Treatment of extracts with phosphatase caused collapse of the Rga2p band, indicating that the reduced electrophoretic mobility is due to phosphorylation ( Figure 6B ). We assayed Rga2p phosphorylation in strains expressing an analogue-sensitive allele of CDC28 (cdc28-as) or PHO85 (pho85-as) that can be specifically inhibited in vivo with the ATP analogue 1NM-PP1 or 1Na-PP1, respectively (Bishop et al, 2000; Carroll et al, 2001) . We failed to detect a substantial change in the timing or level of Rga2p phosphorylation throughout the cell cycle when either PHO85 or CDC28 was singly genetically impaired, either using the as alleles or by removing specific cyclins ( Figure 6C ).
We reasoned that our failure to detect an obvious change in phosphorylation in single CDK mutants reflects the clear genetic redundancy of CDK function (Moffat and Andrews, 2004) . Since cells lacking all G1-CDK activity are inviable, we chose to assay cell cycle-dependent phosphorylation of Rga2 8A p, the version of Rga2p lacking confirmed CDK phosphorylation sites ( Figure 6D ). Cells expressing Rga2 8A p failed to accumulate G1-specific phosphoforms, suggesting that the mutant protein indeed lacks sites that are targeted for phosphorylation in vivo. No additional discernable shift in Rga2 8A p mobility was detectable when the mutant protein was expressed in cln1Dcln2D cells (data not shown). These data support our hypothesis that both Pho85p and Cdc28p contribute to the phosphorylation of Rga2p in G1 phase.
The localization of Rga2p is dependent on phosphorylation by Pho85p and Cdc28p CDK complexes
As noted earlier, the localization of Rga2p is cell cycledependent; Rga2p localizes to the incipient bud site in unbudded cells, whereas small-budded cells display Rga2p at the bud tip. Rga2p fails to localize to any discrete region in medium-budded cells (Caviston et al, 2003) , and relocalizes to the bud neck during mitosis (see Figure 2A) . To assess whether phosphorylation plays a role in proper localization of Rga2p, we examined localization of Rga2p-GFP in various CDK and cyclin mutants. We were unable to detect any significant differences in Rga2p-GFP localization in a pcl1D2D9D, pho85D, cln1Dcln2D, or aDpho85as strain incubated with 25 mM analogue (data not shown). A GFP-tagged version of Rga2 8A p did not exhibit any observable differences in localization relative to wild-type Rga2p-GFP. Examination of Rga2 8A p in a cln1Dcln2Dbackground however revealed a significantly altered localization: (1) more cells displayed signal, including medium-budded cells that do not normally have any localized Rga2p-GFP signal and (2) small and medium-budded cells had more signal along the circumfer-
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Cdc42-GTP 6), and a pcl1D2D9Dmutant (lane7) were incubated with GST-PAK (CRIB) beads that bind Cdc42-GTP. Cdc42p was detected by Western blot using a-Cdc42 antibodies. (B) Removal of the Pho85 G1 cyclins, PCL1 and PCL2, exacerbates the phenotype of cdc24-4 allele-bearing cells. A cdc24-4 pcl1DpGAL-3xHA-PCL2 strain was grown in the presence of glucose (YPD) or galactose (YPG), at a semi-permissive temperature of 301C, and examined by microscopy. Cells were visualized at Â 400 magnification. Size bar is 10 mm.
ence of the bud ( Figure 7A ). Since Rga2 8A p lacks abundant phosphorylation in late G1 phase, we conclude that phosphorylation of Rga2p plays a role in proper localization of this GAP.
Given that substitution of lysine 872 with alanine abrogated the effects of Rga2 8A p overproduction ( Figure 4B , D and E) and substitution of this conserved residue has been shown to abolish GAP-Cdc42p interactions (Gladfelter et al, 2002) , we next examined localization of Cdc42p and Rga2 8A p. Rga2 8A -GFP and mcherry-Cdc42p indeed have a largely overlapping and coincident localization along the circumference of small-budded cln1Dcln2D cells ( Figure 7B ). This observation supports our prediction that Rga2 8A more readily interacts with Cdc42p. In fact, cells overexpressing RGA2 8A fail to localize Cdc42p to a discrete site as required for initiation of bud emergence (Supplementary Figure 5) .
Discussion
The specific morphological events that require G1 CDK activity remain obscure. We have accumulated a substantial body of evidence that identifies the Cdc42 GAP, Rga2p, as a relevant in vivo target of G1 CDKs related to their established role in regulating cell polarity including: (1) RGA2 overexpression in CDK mutant backgrounds produces a significant growth defect and depolarized growth suggestive of GAP hyperactivity; (2) Rga2p is phosphorylated by both G1-specific forms of Pho85p and Cdc28p CDKs in vitro, and physically associates with Pho85p cyclins; (3) Rga2p and G1 Pho85p cyclin localization overlaps at the sites of polarized growth; (4) mutation of CDK consensus sites that are phosphorylated both in vivo and in vitro results in loss of G1 phase-specific phosphorylation of Rga2p, a decrease in activated Cdc42p, and an exacerbation of cdc24 phenotypes reflective of Rga2 8A p hyperactivity; and (5) a failure to completely phosphorylate Rga2p results in localization defects. Rga2p therefore provides a significant link between G1 CDK activity and the Cdc42p GTPase polarity module. Our data suggest that phosphorylation of Rga2p inhibits GAP function to contribute to appropriate activation of Cdc42p during cell polarity establishment.
Previous studies have connected G1 CDKs to activation of the Cdc42 GTPase module. For example, pho85, cln1 cln2, and pcl1 pcl2 mutant strains show synthetic lethal interactions with specific regulators and effectors of Cdc42p (Benton et al, 1993; Cvrckova and Nasmyth, 1993; Lenburg and O'Shea, 2001; Moffat and Andrews, 2004) . Biochemical links have also been uncovered: Rga2p can be phosphorylated by Cdc28as1p-Clb2p in whole-cell extracts (Ubersax et al, 2003) and other Cdc42 GAPs, Bem3p, and Rga1p, physically interact with Cdc28p-Cln2p (Archambault et al, 2004) . While most previous work has linked only Cdc28p with Cdc42p and its regulators, our observations implicate Rga2p as a G1-specific substrate of both Cdc28p and Pho85p. Pho85p and Cdc28p, in complex with their G1 cyclins, can phosphorylate Rga2p in vitro, at overlapping and unique sites and some of these sites are phosphorylated in vivo in a CDKdependent manner. Overexpression of RGA2 in strains deficient in G1-specific forms of either CDK results in arrest as large, unbudded cells, similar to the effects of CDC24 GEF inactivation. Also, we were unable to abolish accumulation of Rga2p G1-phase phosphoforms by impairing either kinase alone. Together, these results suggest that additive phosphorylation by Cdc28p and Pho85p contributes to inhibition of Rga2p activity, perhaps by regulating distinct aspects of Rga2p function. A partnership between CDKs in regulating cell cycle and cell polarity targets is an emerging theme in G1 regulation. Both Cdc28p and Pho85p are involved in phosphorylation of the S-phase CDK inhibitor Sic1, which primes the protein for degradation (Schwob et al, 1994; Nishizawa et al, 1998 
8A p fails to accumulate G1 phase-specific phosphoforms. (A) The phosphorylation of Rga2p-TAP during a cell cycle was monitored by Western blotting using a-TAP antibody. Samples were taken every 15 min for 90 min following alpha-factor block and release. (B) Rga2p-TAP was immunoprecipitated, divided into two aliquots, and one aliquot was treated with 100 U of lambda phosphatase. (C) The phosphorylation of Rga2p-TAP in pcl1Dpcl2Dpcl9D, pho85-as, and cln1Dcln2D cells was monitored during a cell cycle by Western blotting using polyclonal a-TAP antibodies. Samples were taken every 15 min for 90 min following alpha-factor block and release. For the pho85-as (analogue sensitive) strain, cells were released from alpha-factor into the indicated concentration of 1Na-PP1. (D) The phosphorylation of Rga2p-TAP or Rga2 8A p-TAP in wild-type cells was monitored during a cell cycle by Western blotting using a-TAP antibody. Samples were taken every 15 min for 90 min following alpha-factor block and release. Corresponding FACS profiles indicate relative position in the cell cycle. Western blot analysis of Swi6p was used to assess loading. The schematic of Rga2 8A p shows those potential CDK phosphorylation sites (asterisks; S/TP) mutated to alanine. et al, 2004; de Bruin et al, 2004; D Huang and BJ Andrews, unpublished) . Dual regulation by CDKs or other partner kinases may prove to be a common feature of cell cycle regulatory transitions that must be both rapid and responsive. Also, multi-site phosphorylation by one or more kinases may prove to be the rule, rather than the exception, among CDK targets including Rga2p. In fact, a recent computational analysis showed enrichment of multiple closely spaced consensus sites for Cdc28p substrates in yeast, a pattern that proved predictive of likely CDK targets (Moses et al, 2007) . 8A shares overlapping localization with Cdc42p in cln1Dcln2D cells. Those strains from panel A were transformed with pMET-mcherry-CDC42 and examined using spinning-disc confocal microscopy.
The apparent redundancy of Rga2p regulation is also evident through mutational analysis of phosphorylation sites. We analyzed the effects of mutating potential phospho-sites in Rga2p to alanine, in an effort to mimic a nonphosphorylatable residue. We reasoned that if phosphorylation at any particular site was important for Rga2p regulation, overexpression of the relevant phospho-site mutant in otherwise wild-type cells should phenocopy the SDL and morphology defect triggered by overproduction of Rga2p in the associated kinase mutant. We focused our mutagenesis on 13 of the 18 potential phosphorylation sites (S/TP) of Rga2p that are conserved either amongst three Saccharomyces sensu stricto species (Saccharomyces mikatae, Saccharomyces paradoxus, and Saccharomyces bayanus) or among other Cdc42p GAPs. Most of the sites fall within two 'clusters', one near the LIM domain at the N-terminus of Rga2p, and the other adjacent to the GAP domain at the C-terminus (see Figure 3A) . Despite the clear conservation, mutation of any single phosphorylation site in Rga2p was of little phenotypic consequence. Rather, we saw a cumulative effect on growth and cell polarity as additional sites were mutated-overproduction of Rga2 8A p, which carries eight substitutions in both clusters, caused a cell polarity and growth defect comparable to that seen when wild-type RGA2 is overexpressed in CDK mutants.
What are the functional consequences of Rga2p phosphorylation? Our genetic and biochemical data suggest that a failure to phosphorylate Rga2p results in Rga2p GAP hyperactivity and a consequent inability to appropriately activate Cdc42p. First, elimination of GAP activity by mutation of the Rga2p GAP domain restored wild-type growth and morphology to RGA2 8A -expressing cells. Second, Cdc42p-GTP levels were dramatically reduced in extracts from a pho85D mutant, implicating G1 Pho85p CDK complexes specifically. Third, expression of a hypo-phosphorylated version of Rga2p (Rga2 8A p) also decreased levels of activated Cdc42p and exacerbated cdc24 mutant defects, consistent with GAP hyperactivity. We note that cells exhibit considerable tolerance for reduced levels of Cdc42p-GTP, emphasizing the robust nature of the Cdc42p regulatory pathway. A failure to properly inhibit Rga2p may explain previous genetic links between Pho85p and Cdc42p. Deletion of PHO85 causes lethality in a cdc42-1 strain, which has reduced levels of Cdc42p, and arrests with a large, unbudded cell morphology at the restrictive temperature (Kozminski et al, 2000; Huang et al, 2002) . The cdc42-1 strain may be poised on the brink, and a further reduction in Cdc42p-GTP levels due to hyperactive Rga2p in the pho85 deletion strain may be catastrophic.
In addition to the possibility that phosphorylation affects Rga2p GAP activity directly, we entertained the idea that phosphorylation may contribute to the localization of Rga2p. Phosphorylation of the Rho1p-GEF, Tus1p, by Cdc5p is required for localization to the bud neck at cytokinesis (Yoshida et al, 2006) . We however saw no apparent change in Rga2p localization when Cdc28p or Pho85p was separately impaired. Rather, the combination of a hypo-phosphorylated version of Rga2p (Rga2 8A p) with deletion of CLN1 and CLN2 produced obvious localization defects. Despite this abnormal localization, and a clear deficiency in G1-specific phosphorylation of Rga2p ( Figure 6D ), RGA2 8A cln1Dcln2D cells initiate bud formation normally, suggesting that G1 CDKs contribute to the formation of Cdc42p-GTP through other mechanisms besides downregulation of Rga2p. Consistent with this, a strain in which Rga2 8A p is the only GAP available for Cdc42p (an RGA2 8A rga1Dbem3D triple mutant) can still polarize growth (data not shown), albeit erratically as seen for rga2Drga1Dbem3D mutants (Smith et al, 2002) . Likely CDK targets include other factors that contribute to the generation of Cdc42-GTP, such as the other Cdc42p GAPs Bem2p and Bem3p (M Knaus and M Peter, personal communication), which would explain why CDK mutants display a more dramatic reduction in the levels of Cdc42-GTP than that caused by RGA2 8A expression ( Figure 5A ). In addition, G1 CDKs have been shown to phosphorylate the polarity proteins Boi1p and Boi2p (McCusker et al, 2007) , and the septin Shs1p (D Kellogg, personal communication), which likely contribute to efficient polarization. Genetic data suggest that more CDK targets remain to be discovered.
The persistence of Rga2 8A p at the cortex of budded cln1Dcln2Dcells suggests that hypo-phosphorylated Rga2p can still interact physically with Cdc42p. Rga2 8A p may remain inappropriately associated with Cdc42p, since Cdc42p laterally diffuses throughout the plasma membrane of enlarging buds (Richman et al, 2002) . A prolonged interaction of Rga2 8A p and Cdc42p may prevent Cdc42p activation, resulting in a failure to polarize growth when RGA2 8A is overexpressed. Indeed, Cdc42p fails to localize to a discrete site in unbudded cells when RGA2 8A is overexpressed (Supplementary Figure 5) . Confocal microscopy also revealed an overlapping localization for Rga2 8A p and Cdc42p in smallbudded cln1Dcln2D cells ( Figure 7B) . A hyperactive Rga2 8A p-Cdc42p complex could interfere with cycling of Cdc42p-GTP/GDP, which is required for promoting all the aspects of polarizing growth (Caviston et al, 2002; Gladfelter et al, 2002; Irazoqui et al, 2003; Court and Sudbery, 2007) This idea is supported by failure of overexpressed CDC24 or CDC42
G12V
(constitutively active Cdc42p) to rescue the toxicity associated with RGA2 8A overexpression (data not shown). Rga2p phosphorylation may influence its GAP activity and/ or physical interaction with Cdc42p. While we have been able to co-immunoprecipitate Rga2 8A p with the Pcls (data not shown), we have been unable to detect a stabilized interaction between Rga2 8A p and Cdc42p (data not shown). Our data suggest a role for G1-phase CDKs in downregulating Cdc42 GAP activity to ensure appropriate Cdc42p activation during G1 phase. Inhibition of GAPs by CDKs may be a general mechanism to regulate the actin cytoskeleton. For example, the highly elongated morphology of hyphae in Candida albicans is due to increased activity of Cdc42p and deletion of the GAPs RGA2, and BEM3 results in the elongation of pseudohyphal cells (Court and Sudbery, 2007) . Rga2p is phosphorylated in a hyphal-specific manner in C. albicans, indicating that phosphorylation likely inhibits Rga2p during this stage of the Candida life cycle (Court and Sudbery, 2007) . The phosphorylation of mammalian GAPs also alters cytoskeletal network organization and signal transduction; a Cdc42 and Rac1 GAP, CdGAP, is phosphorylated by ERK1/2 in vivo, leading to downregulation of CdGAP activity and consequent Rac1 activation, and cytoskeletal remodeling (Tcherkezian et al, 2005) . Likewise, activity of the Cdc42 and Rac1 GAP, RICS, is inhibited via phosphorylation by calcium/calmodulin-dependent kinase II (Okabe et al, 2003) . In general, regulation of Cdc42p and other Rho-type GTPase modules by CDKs may serve to connect cues from the cell cycle and the actin cytoskeleton to coordinate cell surface growth with cell division. Given the conservation of Rho-type GTPase pathways, regulatory events uncovered in yeast are likely relevant in other eukaryotes. (Tables II and III) Standard yeast growth conditions were used. All yeast gene disruptions were achieved by homologous recombination by standard polymerase chain reaction (PCR)-based methods, and verified by PCR and phenotypic analyses. Point mutants were made using PCR-based site-directed mutagenesis and confirmed by sequencing. Cell size analysis and synchronization were performed as described (Costanzo et al, 2004) .
Materials and methods
Yeast strains and plasmids
Microscopy
Cells were photographed with a CoolSNAP HQ high-speed digital camera (Roeper Scientific) mounted on a Leica DM-LB microscope. Images were captured and analyzed using MetaMorph software (Universal Imaging Media, PA). For confocal microscopy, proteins were visualized with a Leica DMI 6000B fluorescence microscope equipped with a spinning-disc head and an argon laser (458, 488, and 514 nm) (Quorum Technologies), and an ImagEM-CCD camera (Hamamatsu, Japan), and analyzed using Volocity software (distributed by Quorum Technologies Inc., Guelph, ON). Z-stacks of 10 spinning-disc confocal images separated by 0.2 mm were taken.
Kinase assays and mass spectrometry
Recombinant Pcl-Pho85p and Cln2p-Cdc28p kinases were expressed and purified from insect cells as described (Huang et al, 1999) . Substrates included 150 ng of five truncated versions of Rga2p: amino acids 1-240, 233-365, 357-658, 652-795, and 789-1009 (all N-terminal GST fusions were expressed in Escherichia coli and purified using glutathione-Sepharose columns). Kinase reactions were performed as described (Costanzo et al, 2004) . Details of the methods for purifying and processing phosphorylated proteins for mass spectrometry are available at the Andrews lab website (www.utoronto.ca/andrewslab/).
Cdc42 activation assay GTP-bound Cdc42p in different lysates overexpressing CDC24 was detected using a GST-PAK (a GST fusion of the CRIB domain from 
